ArticleMedicine2026

Impact of IL-6 receptor inhibitors on cerebrospinal fluid metabolites in type 2 diabetes patients.

Naidan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.